Benchmark Reiterates Buy on Imax, Maintains $22 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Mike Hickey reiterates a Buy rating on Imax (NYSE:IMAX) and maintains a $22 price target.
April 10, 2024 | 1:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Mike Hickey reiterates a Buy rating on Imax and maintains a $22 price target.
The reiteration of a Buy rating and maintenance of a $22 price target by a Benchmark analyst suggests a positive outlook for Imax's stock. This endorsement could instill confidence in investors, potentially leading to a short-term increase in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100